Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$152K Sell
204,522
-743,185
-78% -$722K ﹤0.01% 10376
2025
Q4
$1.06M Buy
+947,707
New +$1.34M ﹤0.01% 5999
2024
Q4
Sell
-34,495
Closed -$63.5K 10203
2024
Q3
$63.5K Buy
34,495
+17,541
+103% +$29.1K ﹤0.01% 9125
2024
Q2
$32.1K Buy
+16,954
New +$37.9K ﹤0.01% 8994
2024
Q1
Sell
-31,390
Closed -$60.9K 9812
2023
Q4
$60.9K Buy
+31,390
New +$58.8K ﹤0.01% 8739
2023
Q3
Sell
-16,927
Closed -$44.4K 9146
2023
Q2
$44.4K Buy
+16,927
New +$47.2K ﹤0.01% 8234

Other funds holding NVX

Jane Street's NVX Position: Q1 2026 in Review

Jane Street reduced its NOVONIX (NVX) stake by 78% in Q1 2026, selling an estimated $722K and leaving 204,522 shares worth $152K. The position accounts for ﹤0.01% of the portfolio, ranked #10376.

Jane Street first reported a position in NVX in Q2 2023 and has held it in 6 quarters since. The position peaked at $1.06M in Q4 2025. 32 funds tracked by Wall St. Rank hold NVX as of Q1 2026.

  • Jane Street held 204,522 shares of NOVONIX worth $152K as of Q1 2026.
  • Jane Street sold 743,185 NOVONIX shares in Q1 2026, an estimated $722K.
  • NOVONIX made up ﹤0.01% of Jane Street's portfolio in Q1 2026, its #10376 holding.
  • Jane Street first reported a position in NOVONIX in Q2 2023 and has held it in 6 quarters since.
  • Jane Street's NOVONIX position peaked at $1.06M in Q4 2025.
  • 32 funds tracked by Wall St. Rank held NOVONIX as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.